Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 6193106, 11 pages
https://doi.org/10.1155/2017/6193106
Research Article

Y-box Protein-1 Regulates the Expression of Collagen I in Hepatic Progenitor Cells via PDGFR-β/ERK/p90RSK Signalling

1Department of Gastroenterology and Hepatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China
2Gastroenterology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China

Correspondence should be addressed to Mingyi Xu; moc.361@4102iygnimux and Lungen Lu; moc.361@5691ulnegnul

Received 14 January 2017; Accepted 6 April 2017; Published 27 August 2017

Academic Editor: Luca Vanella

Copyright © 2017 Fei Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. Dedier, J. Schiffenbuer, S. L. Woulfe, M. Zacheis, and B. D. Schwartz, “Charaterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box,” PNAS, vol. 85, no. 19, pp. 7322–7326, 1998. View at Google Scholar
  2. T. Okamoto, H. Izumi, T. Imamura et al., “Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression,” Oncogene, vol. 19, no. 54, pp. 6194–6202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Lasham, S. Moloney, T. Hale et al., “The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor,” The Journal of Biological Chemistry, vol. 278, no. 37, pp. 35516–35523, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Harada, Y. Kotake, T. Ohhata et al., “YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers,” Genes to Cells, vol. 19, no. 6, pp. 504–516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Astanehe, M. R. Finkbeiner, M. Krzywinski et al., “MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition,” Oncogene, vol. 31, no. 41, pp. 4434–4446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. L. Stratford, G. Habibi, A. Astanehe et al., “Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy,” Breast Cancer Research, vol. 9, no. 5, p. R61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. T. Norman, G. E. Lindahl, K. Shakib, A. En-Nia, E. Yilmaz, and P. R. Mertens, “The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter,” The Journal of Biological Chemistry, vol. 276, no. 32, pp. 29880–29890, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Harendza, D. H. Lovett, and R. A. K. Stahl, “The hematopoietic transcription factor PU.1 represses gelatinase A transcription in glomerular mesangial cells,” The Journal of Biological Chemistry, vol. 275, no. 26, pp. 19552–19559, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. C. E. Grant and R. G. Deeley, “Cloning and characterization of chicken YB-1: regulation of expression in the liver,” Molecular and Cellular Biology, vol. 13, no. 7, pp. 4186–4196, 1993. View at Publisher · View at Google Scholar
  10. V. P. Gunasekaran and M. Ganeshan, “Inverse correlation of ribosomal protein S27A and multifunctional protein YB-1 in hepatocellular carcinoma,” Clinical Biochemistry, vol. 47, no. 13-14, pp. 1262–1264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Dooley, H. M. Said, A. M. Gressner, J. Floege, A. En-Nia, and P. R. Mertens, “Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects,” The Journal of Biological Chemistry, vol. 281, no. 3, pp. 1784–1795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Inagaki, M. Kushida, K. Higashi et al., “Cell type-specific intervention of transforming growth factor β/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice,” Gastroenterology, vol. 129, no. 1, pp. 259–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Akhurst, E. J. Croager, C. A. Farley-Roche et al., “A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver,” Hepatology, vol. 34, no. 3, pp. 519–522, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Czochra, B. Klopcic, E. Meyer et al., “Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice,” Journal of Hepatology, vol. 45, no. 3, pp. 419–428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Borkham-Kamphorst and R. Weiskirchen, “The PDGF system and its antagonists in liver fibrosis,” Cytokine & Growth Factor Reviews, vol. 28, pp. 53–61, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Kocabayoglu, A. Lade, Y. A. Lee et al., “Beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis,” Journal of Hepatology, vol. 63, no. 1, pp. 141–147, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. N. Jhandier, E. A. Kruglov, E. G. Lavoie, J. Sévigny, and J. A. Dranoff, “Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2,” The Journal of Biological Chemistry, vol. 280, no. 24, pp. 22986–22992, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Kisseleva, H. Uchinami, N. Feirt et al., “Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis,” Journal of Hepatology, vol. 45, no. 3, pp. 429–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. J. Forbes, F. P. Russo, V. Rey et al., “A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis,” Gastroenterology, vol. 126, no. 4, pp. 955–963, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Beaussier, D. Wendum, E. Schiffer et al., “Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries,” Laboratory Investigation, vol. 87, no. 3, pp. 292–303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Wang, M. Cong, T. Liu et al., “The characteristics variation of hepatic progenitors after TGF-beta1-induced transition and EGF-induced reversion,” Stem Cells International, vol. 2016, Article ID 6304385, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. N. K. M. Van Hul, J. Abarca-Quinones, C. Sempoux, Y. Horsmans, and I. A. Leclercq, “Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury,” Hepatology, vol. 49, no. 5, pp. 1625–1635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. A. Lazaro, J. A. Rhim, Y. Yamada, and N. Fausto, “Generation of hepatocytes from oval cell precursors in culture,” Cancer Research, vol. 58, no. 23, pp. 5514–5522, 1998. View at Google Scholar
  24. S. Shin, G. Walton, R. Aoki et al., “Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential,” Genes & Development, vol. 25, no. 11, pp. 1185–1192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Espanol-Suner, R. Carpentier, N. Van Hul et al., “Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice,” Gastroenterology, vol. 143, no. 6, pp. 1564.e7–1575.e7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Higashi, Y. Inagaki, K. Fujimori, A. Nakao, H. Kaneko, and I. Nakatsuka, “Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3,” The Journal of Biological Chemistry, vol. 278, no. 44, pp. 43470–43479, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Demoulin and A. Essaghir, “PDGF receptor signaling networks in normal and cancer cells,” Cytokine & Growth Factor Reviews, vol. 25, no. 3, pp. 273–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. K. Lau, Z. F. Yang, D. W. Ho et al., “An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells,” Clinical Cancer Research, vol. 15, no. 10, pp. 3462–3471, 2009. View at Publisher · View at Google Scholar · View at Scopus